XML 19 R7.htm IDEA: XBRL DOCUMENT v3.23.3
Condensed Consolidated Statements of Stockholders' Equity (Unaudited) - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive (Loss)/Income
Retained Earnings (Accumulated Deficit)
Equity, beginning balance (in shares) at Dec. 31, 2021   137,498      
Equity, beginning balance at Dec. 31, 2021 $ 196,953 $ 138 $ 256,347 $ (620) $ (58,912)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 17,174   17,174    
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes (in shares)   1,512      
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes 1,693 $ 1 1,692    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under ESPP plan (in shares)   753      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 7,081 $ 1 7,080    
Capped call transaction (69,120)   (69,120)    
Repurchase of common stock (shares)   (4,552)      
Repurchase of common stock (200,001) $ (5) (199,996)    
Other comprehensive income (loss) (1,216)     (1,216)  
Net income 144,427       144,427
Equity, ending balance (in shares) at Sep. 30, 2022   135,211      
Equity, ending balance at Sep. 30, 2022 96,991 $ 135 13,177 (1,836) 85,515
Equity, beginning balance (in shares) at Jun. 30, 2022   137,681      
Equity, beginning balance at Jun. 30, 2022 293,171 $ 138 271,169 (2,017) 23,881
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 6,797   6,797    
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes (in shares)   1,512      
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes 1,693 $ 1 1,692    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under ESPP plan (in shares)   137      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 2,636 $ 1 2,635    
Capped call transaction (69,120)   (69,120)    
Repurchase of common stock (shares)   (4,119)      
Repurchase of common stock (200,001) $ (5) (199,996)    
Other comprehensive income (loss) 181     181  
Net income 61,634       61,634
Equity, ending balance (in shares) at Sep. 30, 2022   135,211      
Equity, ending balance at Sep. 30, 2022 96,991 $ 135 13,177 (1,836) 85,515
Equity, beginning balance (in shares) at Dec. 31, 2022   135,154      
Equity, beginning balance at Dec. 31, 2022 169,798 $ 135 27,368 (922) 143,217
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 26,956   26,956    
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes (in shares)   289      
Issuance of common stock for conversion of 2024 Convertible Notes/ induced conversion related to convertible notes (126) $ 0 (126)    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under ESPP plan (in shares)   803      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 5,499 $ 1 5,498    
Repurchase of common stock (shares)   (4,165)      
Repurchase of common stock (151,301) $ (4) (34,159)   (117,138)
Other comprehensive income (loss) 2,149     2,149  
Net income 196,206       196,206
Equity, ending balance (in shares) at Sep. 30, 2023   132,081      
Equity, ending balance at Sep. 30, 2023 249,181 $ 132 25,537 1,227 222,285
Equity, beginning balance (in shares) at Jun. 30, 2023   131,856      
Equity, beginning balance at Jun. 30, 2023 151,033 $ 132 12,068 (1,615) 140,448
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Share-based compensation expense 9,367   9,367    
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under ESPP plan (in shares)   225      
Issuance of common stock pursuant to exercise of stock options and vesting of restricted stock and performance stock units, net and shares issued under the ESPP plan 4,102 $ 0 4,102    
Other comprehensive income (loss) 2,842     2,842  
Net income 81,837       81,837
Equity, ending balance (in shares) at Sep. 30, 2023   132,081      
Equity, ending balance at Sep. 30, 2023 $ 249,181 $ 132 $ 25,537 $ 1,227 $ 222,285